Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancer. Read more about Changing the way we do business: recommendations to accelerate biomarker development in pancreatic cancer.
Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes. Read more about Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes.
Does microenvironment contribute to the etiology of estrogen receptor-negative breast cancer? Read more about Does microenvironment contribute to the etiology of estrogen receptor-negative breast cancer?
Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance. Read more about Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance.
c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met. Read more about c-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-Met.
Targeted isotretinoin in neuroblastoma: kinetics, genetics, or absorption. Read more about Targeted isotretinoin in neuroblastoma: kinetics, genetics, or absorption.
Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy. Read more about Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.
Secrets of drug resistance in NSCLC exposed by new molecular definition of EMT. Read more about Secrets of drug resistance in NSCLC exposed by new molecular definition of EMT.
miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Read more about miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping. Read more about Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping.
